Knocking down PVT1 significantly reduced tumor volume in bladder, prostate, breast, and lung cancer, as well as hepatocellular carcinoma and glioma (24, 25, 37, 48, 55, 63, 66). Here, PVT1 is linked to central nervous system cancer.